HEADER HYDROLASE 06-JUN-06 2IUL TITLE HUMAN TACE G13 MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 68-658; COMPND 5 SYNONYM: HUMAN TESTIS ACE G13 MUTANT, TESTIS-SPECIFIC ISOFORM, ACE-T, COMPND 6 DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II; COMPND 7 EC: 3.4.15.1, 3.2.1.-; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: CHINESE HAMSTER OVARY CELLS KEYWDS HYDROLASE, PHOSPHORYLATION, CARBOXYPEPTIDASE, METAL-BINDING, KEYWDS 2 TRANSMEMBRANE, METALLOPROTEASE, PEPTIDYL DIPEPTIDASE, ALTERNATIVE KEYWDS 3 SPLICING, TYPE-I MEMBRANE-ANCHORED PROTEIN, GLYCOSIDASE, KEYWDS 4 POLYMORPHISM, GLYCOPROTEIN, AC, ZINC, MUTANT, MEMBRANE, CHLORIDE, KEYWDS 5 PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.WATERMEYER,B.T.SEWELL,R.NATESH,H.R.CORRADI,K.R.ACHARYA, AUTHOR 2 E.D.STURROCK REVDAT 5 06-NOV-24 2IUL 1 REMARK REVDAT 4 13-DEC-23 2IUL 1 REMARK HETSYN REVDAT 3 29-JUL-20 2IUL 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 24-FEB-09 2IUL 1 VERSN REVDAT 1 25-OCT-06 2IUL 0 JRNL AUTH J.M.WATERMEYER,B.T.SEWELL,S.L.SCHWAGER,R.NATESH,H.R.CORRADI, JRNL AUTH 2 K.R.ACHARYA,E.D.STURROCK JRNL TITL STRUCTURE OF TESTIS ACE GLYCOSYLATION MUTANTS AND EVIDENCE JRNL TITL 2 FOR CONSERVED DOMAIN MOVEMENT. JRNL REF BIOCHEMISTRY V. 45 12654 2006 JRNL REFN ISSN 0006-2960 JRNL PMID 17042482 JRNL DOI 10.1021/BI061146Z REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 40225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1297 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.02 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2172 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4755 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 85 REMARK 3 SOLVENT ATOMS : 335 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.10000 REMARK 3 B22 (A**2) : -0.26000 REMARK 3 B33 (A**2) : 0.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.192 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.163 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.097 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.374 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4972 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6780 ; 1.198 ; 1.954 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 589 ; 5.178 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 243 ;35.326 ;24.115 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 790 ;14.138 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;20.780 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 727 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3823 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2389 ; 0.189 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3411 ; 0.302 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 316 ; 0.125 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 56 ; 0.201 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.114 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3024 ; 0.603 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4722 ; 0.972 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2286 ; 1.465 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2054 ; 2.249 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2IUL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1290029010. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.70 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40225 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.21000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1O8A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM ACETATE PH4.7 15%, PEG REMARK 280 4000, 10UM ZINC SULPHATE, PH 4.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.31650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.23300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.36150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.23300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.31650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.36150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CONVERTS ANGIOTENSIN I TO ANGIOTENSIN II BY RELEASE OF REMARK 400 THE TERMINAL HIS-LEU, THIS RESULTS IN AN INCREASE OF THE REMARK 400 VASOCONSTRICTOR ACTIVITY OF ANGIOTENSIN. ALSO ABLE TO INACTIVATE REMARK 400 BRADYKININ, A POTENT VASODILATOR. HAS ALSO A GLYCOSIDASE ACTIVITY REMARK 400 WHICH RELEASES GPI-ANCHORED PROTEINS FROM THE MEMBRANE BY CLEAVING REMARK 400 THE MANNOSE LINKAGE IN THE GPI MOIETY (BY SIMILARITY). REMARK 400 REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 121 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 186 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 368 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 617 TO GLN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 37 REMARK 465 VAL A 38 REMARK 465 THR A 39 REMARK 465 GLU A 436 REMARK 465 ASN A 624 REMARK 465 SER A 625 REMARK 465 ALA A 626 REMARK 465 ARG A 627 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 79 CG CD CE NZ REMARK 480 GLN A 98 CG CD OE1 NE2 REMARK 480 GLN A 106 CG CD OE1 NE2 REMARK 480 GLN A 108 CB CG CD OE1 NE2 REMARK 480 LYS A 113 CE NZ REMARK 480 LYS A 117 CD CE NZ REMARK 480 SER A 298 OG REMARK 480 GLU A 303 CG CD OE1 OE2 REMARK 480 LYS A 307 CG CD CE NZ REMARK 480 LYS A 363 CE NZ REMARK 480 LYS A 425 CE NZ REMARK 480 LYS A 613 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2215 O HOH A 2216 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 113 CD LYS A 113 CE -0.263 REMARK 500 LYS A 117 CG LYS A 117 CD 0.229 REMARK 500 SER A 298 CB SER A 298 OG 0.170 REMARK 500 LYS A 425 CD LYS A 425 CE 0.253 REMARK 500 LYS A 613 CD LYS A 613 CE -0.187 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 113 CG - CD - CE ANGL. DEV. = 28.2 DEGREES REMARK 500 LYS A 113 CD - CE - NZ ANGL. DEV. = 39.5 DEGREES REMARK 500 LYS A 613 CG - CD - CE ANGL. DEV. = -24.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 72 74.51 -166.61 REMARK 500 GLU A 123 -129.59 50.28 REMARK 500 ASP A 300 98.32 -66.58 REMARK 500 LYS A 363 -39.04 -134.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 152 HIS A 153 145.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1634 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 383 NE2 REMARK 620 2 HIS A 387 NE2 107.8 REMARK 620 3 GLU A 411 OE1 91.0 106.1 REMARK 620 4 ACT A1627 O 117.5 127.6 98.2 REMARK 620 5 ACT A1627 OXT 99.5 94.8 152.5 54.5 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O86 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME IN COMPLEX REMARK 900 WITH LISINOPRIL. REMARK 900 RELATED ID: 1O8A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME (NATIVE). REMARK 900 RELATED ID: 1UZE RELATED DB: PDB REMARK 900 COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRIL AN THE HUMAN REMARK 900 TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 1UZF RELATED DB: PDB REMARK 900 COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN REMARK 900 TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 2IUX RELATED DB: PDB REMARK 900 HUMAN TACE MUTANT G1234 DBREF 2IUL A 37 627 UNP P22966 ACET_HUMAN 68 658 SEQADV 2IUL GLN A 90 UNP P22966 ASN 121 ENGINEERED MUTATION SEQADV 2IUL GLN A 155 UNP P22966 ASN 186 ENGINEERED MUTATION SEQADV 2IUL GLN A 337 UNP P22966 ASN 368 ENGINEERED MUTATION SEQADV 2IUL GLN A 586 UNP P22966 ASN 617 ENGINEERED MUTATION SEQRES 1 A 591 LEU VAL THR ASP GLU ALA GLU ALA SER LYS PHE VAL GLU SEQRES 2 A 591 GLU TYR ASP ARG THR SER GLN VAL VAL TRP ASN GLU TYR SEQRES 3 A 591 ALA GLU ALA ASN TRP ASN TYR ASN THR ASN ILE THR THR SEQRES 4 A 591 GLU THR SER LYS ILE LEU LEU GLN LYS ASN MET GLN ILE SEQRES 5 A 591 ALA GLN HIS THR LEU LYS TYR GLY THR GLN ALA ARG LYS SEQRES 6 A 591 PHE ASP VAL ASN GLN LEU GLN ASN THR THR ILE LYS ARG SEQRES 7 A 591 ILE ILE LYS LYS VAL GLN ASP LEU GLU ARG ALA ALA LEU SEQRES 8 A 591 PRO ALA GLN GLU LEU GLU GLU TYR ASN LYS ILE LEU LEU SEQRES 9 A 591 ASP MET GLU THR THR TYR SER VAL ALA THR VAL CYS HIS SEQRES 10 A 591 PRO GLN GLY SER CYS LEU GLN LEU GLU PRO ASP LEU THR SEQRES 11 A 591 ASN VAL MET ALA THR SER ARG LYS TYR GLU ASP LEU LEU SEQRES 12 A 591 TRP ALA TRP GLU GLY TRP ARG ASP LYS ALA GLY ARG ALA SEQRES 13 A 591 ILE LEU GLN PHE TYR PRO LYS TYR VAL GLU LEU ILE ASN SEQRES 14 A 591 GLN ALA ALA ARG LEU ASN GLY TYR VAL ASP ALA GLY ASP SEQRES 15 A 591 SER TRP ARG SER MET TYR GLU THR PRO SER LEU GLU GLN SEQRES 16 A 591 ASP LEU GLU ARG LEU PHE GLN GLU LEU GLN PRO LEU TYR SEQRES 17 A 591 LEU ASN LEU HIS ALA TYR VAL ARG ARG ALA LEU HIS ARG SEQRES 18 A 591 HIS TYR GLY ALA GLN HIS ILE ASN LEU GLU GLY PRO ILE SEQRES 19 A 591 PRO ALA HIS LEU LEU GLY ASN MET TRP ALA GLN THR TRP SEQRES 20 A 591 SER ASN ILE TYR ASP LEU VAL VAL PRO PHE PRO SER ALA SEQRES 21 A 591 PRO SER MET ASP THR THR GLU ALA MET LEU LYS GLN GLY SEQRES 22 A 591 TRP THR PRO ARG ARG MET PHE LYS GLU ALA ASP ASP PHE SEQRES 23 A 591 PHE THR SER LEU GLY LEU LEU PRO VAL PRO PRO GLU PHE SEQRES 24 A 591 TRP GLN LYS SER MET LEU GLU LYS PRO THR ASP GLY ARG SEQRES 25 A 591 GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR ASN SEQRES 26 A 591 GLY LYS ASP PHE ARG ILE LYS GLN CYS THR THR VAL ASN SEQRES 27 A 591 LEU GLU ASP LEU VAL VAL ALA HIS HIS GLU MET GLY HIS SEQRES 28 A 591 ILE GLN TYR PHE MET GLN TYR LYS ASP LEU PRO VAL ALA SEQRES 29 A 591 LEU ARG GLU GLY ALA ASN PRO GLY PHE HIS GLU ALA ILE SEQRES 30 A 591 GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO LYS HIS SEQRES 31 A 591 LEU HIS SER LEU ASN LEU LEU SER SER GLU GLY GLY SER SEQRES 32 A 591 ASP GLU HIS ASP ILE ASN PHE LEU MET LYS MET ALA LEU SEQRES 33 A 591 ASP LYS ILE ALA PHE ILE PRO PHE SER TYR LEU VAL ASP SEQRES 34 A 591 GLN TRP ARG TRP ARG VAL PHE ASP GLY SER ILE THR LYS SEQRES 35 A 591 GLU ASN TYR ASN GLN GLU TRP TRP SER LEU ARG LEU LYS SEQRES 36 A 591 TYR GLN GLY LEU CYS PRO PRO VAL PRO ARG THR GLN GLY SEQRES 37 A 591 ASP PHE ASP PRO GLY ALA LYS PHE HIS ILE PRO SER SER SEQRES 38 A 591 VAL PRO TYR ILE ARG TYR PHE VAL SER PHE ILE ILE GLN SEQRES 39 A 591 PHE GLN PHE HIS GLU ALA LEU CYS GLN ALA ALA GLY HIS SEQRES 40 A 591 THR GLY PRO LEU HIS LYS CYS ASP ILE TYR GLN SER LYS SEQRES 41 A 591 GLU ALA GLY GLN ARG LEU ALA THR ALA MET LYS LEU GLY SEQRES 42 A 591 PHE SER ARG PRO TRP PRO GLU ALA MET GLN LEU ILE THR SEQRES 43 A 591 GLY GLN PRO GLN MET SER ALA SER ALA MET LEU SER TYR SEQRES 44 A 591 PHE LYS PRO LEU LEU ASP TRP LEU ARG THR GLU ASN GLU SEQRES 45 A 591 LEU HIS GLY GLU LYS LEU GLY TRP PRO GLN TYR ASN TRP SEQRES 46 A 591 THR PRO ASN SER ALA ARG MODRES 2IUL ASN A 72 ASN GLYCOSYLATION SITE MODRES 2IUL ASN A 109 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET BMA B 4 11 HET FUC B 5 10 HET NAG A1624 14 HET ACT A1627 4 HET ACT A1628 4 HET CL A1629 1 HET CL A1630 1 HET ZN A1634 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 2 FUC C6 H12 O5 FORMUL 4 ACT 2(C2 H3 O2 1-) FORMUL 6 CL 2(CL 1-) FORMUL 8 ZN ZN 2+ FORMUL 9 HOH *335(H2 O) HELIX 1 1 ASP A 40 THR A 71 1 32 HELIX 2 2 THR A 74 ARG A 100 1 27 HELIX 3 3 ASP A 103 LEU A 107 5 5 HELIX 4 4 ASN A 109 GLN A 120 1 12 HELIX 5 5 LEU A 122 LEU A 127 5 6 HELIX 6 6 PRO A 128 ALA A 149 1 22 HELIX 7 7 PRO A 163 SER A 172 1 10 HELIX 8 8 LYS A 174 ALA A 189 1 16 HELIX 9 9 ALA A 189 GLN A 195 1 7 HELIX 10 10 PHE A 196 ASN A 211 1 16 HELIX 11 11 ASP A 215 SER A 222 1 8 HELIX 12 12 MET A 223 GLU A 225 5 3 HELIX 13 13 SER A 228 LEU A 240 1 13 HELIX 14 14 LEU A 240 GLY A 260 1 21 HELIX 15 15 TRP A 283 ASN A 285 5 3 HELIX 16 16 ILE A 286 VAL A 291 1 6 HELIX 17 17 ASP A 300 GLN A 308 1 9 HELIX 18 18 THR A 311 LEU A 326 1 16 HELIX 19 19 PRO A 332 SER A 339 1 8 HELIX 20 20 ASN A 374 TYR A 394 1 21 HELIX 21 21 PRO A 398 ARG A 402 5 5 HELIX 22 22 ASN A 406 SER A 422 1 17 HELIX 23 23 THR A 423 LEU A 430 1 8 HELIX 24 24 SER A 439 ASP A 473 1 35 HELIX 25 25 ASN A 480 GLY A 494 1 15 HELIX 26 26 PHE A 506 LYS A 511 5 6 HELIX 27 27 TYR A 520 ALA A 541 1 22 HELIX 28 28 PRO A 546 CYS A 550 5 5 HELIX 29 29 SER A 555 LEU A 568 1 14 HELIX 30 30 PRO A 573 GLY A 583 1 11 HELIX 31 31 ALA A 589 HIS A 610 1 22 SHEET 1 AA 2 THR A 150 CYS A 152 0 SHEET 2 AA 2 CYS A 158 GLN A 160 -1 O LEU A 159 N VAL A 151 SHEET 1 AB 2 ILE A 270 PRO A 271 0 SHEET 2 AB 2 LEU A 495 CYS A 496 1 N CYS A 496 O ILE A 270 SHEET 1 AC 2 SER A 355 ASP A 358 0 SHEET 2 AC 2 PHE A 365 LYS A 368 -1 O ARG A 366 N TRP A 357 SSBOND 1 CYS A 152 CYS A 158 1555 1555 2.05 SSBOND 2 CYS A 352 CYS A 370 1555 1555 2.04 SSBOND 3 CYS A 538 CYS A 550 1555 1555 2.03 LINK ND2 ASN A 72 C1 NAG A1624 1555 1555 1.48 LINK ND2 ASN A 109 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O6 NAG B 1 C1 FUC B 5 1555 1555 1.34 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.44 LINK O3 BMA B 3 C1 BMA B 4 1555 1555 1.45 LINK NE2 HIS A 383 ZN ZN A1634 1555 1555 2.05 LINK NE2 HIS A 387 ZN ZN A1634 1555 1555 2.05 LINK OE1 GLU A 411 ZN ZN A1634 1555 1555 1.99 LINK O ACT A1627 ZN ZN A1634 1555 1555 2.04 LINK OXT ACT A1627 ZN ZN A1634 1555 1555 2.48 CISPEP 1 GLU A 162 PRO A 163 0 12.18 CISPEP 2 GLY A 437 GLY A 438 0 2.24 CRYST1 56.633 84.723 134.466 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017658 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011803 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007437 0.00000